• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by PACS Group Inc.

    11/14/24 11:37:42 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care
    Get the next $PACS alert in real time by email
    SC 13G 1 pacs13gbody-093024.htm  


    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

    SCHEDULE 13G*
    (Rule 13d-102)

    INFORMATION TO BE INCLUDED
    IN STATEMENTS FILED PURSUANT
    TO RULES 13d-1(b), (c), AND
    (d) AND AMENDMENTS THERETO
    FILED PURSUANT TO RULE 13d-2
    (Initial Filing)*

    PACS Group, Inc.
    (Name of Issuer)
    Common Stock
     
    (Title of Class of Securities)
    69380Q107
     
    (CUSIP Number)
    September 30, 2024
     
    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [x] Rule 13d-1(b)
    ☐ Rule 13d-1(c)
    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    1
    NAMES OF REPORTING PERSONS
      
     Cohen & Steers, Inc. 14-1904657
      
      
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
      
    (a)☐
      
    (b)[x]
      
    3
    SEC USE ONLY
      
       
      
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
      
     Delaware
      
      
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
      
     8,424,695
      
      
    6
    SHARED VOTING POWER
      
     0
      
      
    7
    SOLE DISPOSITIVE POWER
      
     9,638,455
      
      
    8
    SHARED DISPOSITIVE POWER
      
     0
      
      
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      
     9,638,455
      
      
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      
    ☐
      
      
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
      
     6.21%
      
      
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
      
     HC, CO
      
      









    1
    NAMES OF REPORTING PERSONS
      
     Cohen & Steers Capital Management, Inc.     13-3353336
      
      
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
      
    (a)☐
      
    (b)[x]
      
    3
    SEC USE ONLY
      
       
      
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
      
     New York
      
      
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
      
     8,397,718
      
      
    6
    SHARED VOTING POWER
      
     0
      
      
    7
    SOLE DISPOSITIVE POWER
      
     9,611,478
      
      
    8
    SHARED DISPOSITIVE POWER
      
     0
      
      
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      
     9,611,478
      
      
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      
    ☐
      
      
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
      
     6.19%
      
      
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
      
     IA, CO
      
      







    1
    NAMES OF REPORTING PERSONS
      
     Cohen & Steers UK Limited
      
      
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
      
    (a)☐
      
    (b)[x]
      
    3
    SEC USE ONLY
      
       
      
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
      
     United Kingdom
      
      
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
      
     20,157
      
      
    6
    SHARED VOTING POWER
      
     0
      
      
    7
    SOLE DISPOSITIVE POWER
      
     20,157
      
      
    8
    SHARED DISPOSITIVE POWER
      
     0
      
      
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      
     20,157
      
      
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      
    ☐
      
      
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
      
     0.01%
      
      
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
      
     IA, CO
      
      








    1
    NAMES OF REPORTING PERSONS
      
     Cohen & Steers Asia Limited
      
      
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
      
    (a)☐
      
    (b)[x]
      
    3
    SEC USE ONLY
      
       
      
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
      
     Hong Kong
      
      
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
      
     0
      
      
    6
    SHARED VOTING POWER
      
     0
      
      
    7
    SOLE DISPOSITIVE POWER
      
     0
      
      
    8
    SHARED DISPOSITIVE POWER
      
     0
      
      
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      
     0
      
      
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      
    ☐
      
      
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
      
     0.00%
      
      
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
      
     IA, CO
      
      




    1
    NAMES OF REPORTING PERSONS
      
     Cohen & Steers Ireland Limited
      
      
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
      
    (a)☐
      
    (b)[x]
      
    3
    SEC USE ONLY
      
       
      
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
      
     Ireland
      
      
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
      
     6,820
      
      
    6
    SHARED VOTING POWER
      
     0
      
      
    7
    SOLE DISPOSITIVE POWER
      
     6,820
      
      
    8
    SHARED DISPOSITIVE POWER
      
     0
      
      
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      
     6,820
      
      
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      
    ☐
      
      
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
      
     0.004%
      
      
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
      
     FI, CO
      
      







    Item 1(a).
    Name of Issuer:
    PACS Group, Inc.
     



    Item 1(b).
    Address of Issuer's Principal Executive Offices:
     
    262 North University Avenue
    Farmington, UT 84025
     



    Item 2(a).
    Name of Person Filing:
    Cohen & Steers, Inc.
    Cohen & Steers Capital Management, Inc.
    Cohen & Steers UK Ltd
    Cohen & Steers Asia Ltd
    Cohen & Steers Ireland Ltd
      



    Item 2(b).
    Address of Principal Business Office or, if none, Residence:
     
    The principal address for Cohen & Steers, Inc.
    and Cohen & Steers Capital Management, Inc. is:
    1166 Avenue of the Americas, 30th Floor
    New York, NY 10036
     
    The principal address for Cohen & Steers UK Ltd. is:
    The Burlian, 2nd Floor
    3 Dering Street, London W1S 1AA
    United Kingdom
     
    The principal address for Cohen & Steers Asia Ltd. is:
    1201-02 Champion Tower
    Three Garden Road
    Central, Hong Kong
     
    The principal address for Cohen & Steers Ireland Ltd. is:
    77 Sir John Rogerson's Quay
    Block C, Grand Canal Docklands
    Dublin 2, D02 VK60
     
     
     
     







    Item 2(c).
    Citizenship:
    Cohen & Steers, Inc: Delaware corporation
    Cohen & Steers Capital Management, Inc: New York corporation
    Cohen & Steers UK Ltd: United Kingdom Private Limited Company
    Cohen & Steers Asia Ltd: Asia Private Limited Company
    Cohen & Steers Ireland Ltd: Ireland Private Limited Company



    Item 2(d).
    Title of Class of Securities:
    Common Stock



    Item 2(e).
    CUSIP Number:
    69380Q107






    Item 3.
    If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or
    240.13d-2(b) or (c), Check Whether the Person Filing Is a(n):

    (a)
    ☐ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);

    (b)
    ☐ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);

    (c)
    ☐ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);

    (d)
    ☐ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

    (e)
    [x] Investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E);

    (f)
    ☐ Employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F);

    (g)
    [x] Parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G);

    (h)
    ☐ Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

    (i)
    ☐ Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

    (j)
    [x] A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J);

    (k)
    ☐ Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________________________ .

    Item 4.
    Ownership.

    (a)
    Amount beneficially owned as of September 30, 2024: 
    See row 9 cover sheet

    (b)
    Percent of class:
    See row 11 on cover sheet

    (c)
    Number of shares as to which the person has:

    (i)
    Sole power to vote or to direct the vote:
               See row 5 on cover sheet

    (ii)
    Shared power to vote or to direct the vote:
                       See row 6 on cover sheet

    (iii)
    Sole power to dispose or to direct the disposition of:
                       See row 7 on cover sheet

    (iv)
    Shared power to dispose or to direct the disposition of:
                       See row 8 on cover sheet
    Item 5.
    Ownership of Five Percent or Less of a Class.
    N/A

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

    Item 6.
    Ownership of More Than Five Percent on Behalf of Another Person.
    Each of Cohen & Steers Capital Management, Inc., Cohen & Steers UK Ltd., Cohen & Steers Asia Ltd. and Cohen & Steers Ireland Ltd. holds the securities of the Issuer to which this statement relates for the benefit of their respective account holders.  Such account holders have the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, the securities of the Issuer that are held on their behalf.




    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
    Cohen & Steers, Inc. holds a 100% interest in Cohen & Steers Capital Management, Inc., Cohen & Steers UK Ltd., Cohen & Steers Asia Ltd. (investment advisors registered under Section 203 of the Investment Advisers Act) and Cohen & Steers Ireland Ltd. (a non-US institution).



    Item 8.
    Identification and Classification of Members of the Group.
    N/A



    Item 9.
    Notice of Dissolution of Group.
    N/A





    Item 10.
    Certification.

    By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
    By signing below, I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to Cohen & Steers Ireland Ltd is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution. I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.  I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D filed by Cohen & Steers Ireland Ltd.

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: November 14, 2024

     
    Cohen & Steers, Inc.
    Cohen & Steers Capital Management, Inc
      
     
    By:
     /s/ Francis Poli
      
    Name: Francis Poli
      
    Title: EVP, General Counsel and Global CCO

     
    Cohen & Steers UK Limited
      
     
    By:
     /s/ Natalie Okorie
      
    Name: Natalie Okorie
      
    Title: VP, Compliance Officer

     
    Cohen & Steers Asia Limited
      
     
    By:
     /s/ Catherine Cheng
      
    Name: Catherine Cheng
      
    Title: VP, Compliance Officer

     
    Cohen & Steers Ireland Limited
      
     
    By:
     /s/ Alan Cooper
      
    Name: Alan Cooper
      
    Title: VP, Compliance Officer
























    JOINT FILING AGREEMENT

    In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned  hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a Statement on Schedule 13G including
    amendments thereto with respect to the Common Shares of PACS Group, Inc. and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which together shall constitute one and the same instrument.

             IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of November 14, 2024.

     
    Cohen & Steers, Inc.
    Cohen & Steers Capital Management, Inc
      
     
    By:
     /s/ Francis Poli
      
    Name: Francis Poli
      
    Title: EVP, General Counsel and Global CCO

     
    Cohen & Steers UK Limited
      
     
    By:
     /s/ Natalie Okorie
      
    Name: Natalie Okorie
      
    Title: VP, Compliance Officer

     
    Cohen & Steers Asia Limited
      
     
    By:
     /s/ Catherine Cheng
      
    Name: Catherine Cheng
      
    Title: VP, Compliance Officer

     
    Cohen & Steers Ireland Limited
      
     
    By:
     /s/ Alan Cooper
      
    Name: Alan Cooper
      
    Title: VP, Compliance Officer




    Get the next $PACS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PACS

    DatePrice TargetRatingAnalyst
    12/17/2024$18.00Overweight → Neutral
    Analyst
    11/6/2024$40.00Overweight
    JP Morgan
    10/9/2024$50.00Buy
    UBS
    9/11/2024$45.00Buy
    Citigroup
    6/28/2024$35.00Outperform
    Macquarie
    More analyst ratings

    $PACS
    SEC Filings

    See more
    • SEC Form NT 10-Q filed by PACS Group Inc.

      NT 10-Q - PACS Group, Inc. (0002001184) (Filer)

      5/16/25 4:10:12 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • PACS Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

      8-K - PACS Group, Inc. (0002001184) (Filer)

      4/1/25 8:24:03 AM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • SEC Form NT 10-K filed by PACS Group Inc.

      NT 10-K - PACS Group, Inc. (0002001184) (Filer)

      4/1/25 8:23:06 AM ET
      $PACS
      Hospital/Nursing Management
      Health Care

    $PACS
    Financials

    Live finance-specific insights

    See more
    • PACS Group Provides Preliminary Third Quarter Operational Metrics

      Postpones Third Quarter 2024 Financial Results Conference Call PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), today provided select preliminary key operating metrics for the third quarter and announced the postponement of the release of its third quarter 2024 financial results. PACS expects to release its third quarter 2024 financial results as soon as practicable. "PACS Group operates in a highly regulated industry where compliance is of the utmost importance," said Jason Murray, PACS's Chief Executive Officer. "We believe recent third-party allegations are misleading. However, in line with our commitment to holding ourselves to a high standard – in how we serve our patients, op

      11/6/24 6:00:00 AM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • PACS Group to Announce Third Quarter 2024 Financial Results

      PACS Group, Inc. (NYSE:PACS) ("PACS Group" or the "Company"), today announced that it will release its third quarter 2024 financial results after market close on Thursday, November 7, 2024. Management will host a call on Thursday, November 7, 2024, at 5:00 p.m. Eastern Time to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://ir.pacs.com/ or https://event.choruscall.com/mediaframe/webcast.html?webcastid=ngVWINHF or by dialing 877-407-0621 / +1 215-268-9899. A recording of the call will be available for replay via the website for

      10/31/24 12:00:00 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • PACS Group to Announce Second Quarter 2024 Financial Results

      PACS Group, Inc. (NYSE:PACS) ("PACS Group" or the "Company"), today announced that it will release its second quarter 2024 financial results after market close on Monday, August 12, 2024. Management will host a call on Monday, August 12, 2024, at 5:00 p.m. Eastern Time to discuss the financial results and related information. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240806841957/en/PACS headquarters in Farmington, Utah. (Photo: Business Wire) PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Group website at https://IR.pacs.com, or https://e

      8/6/24 3:49:00 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care

    $PACS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by PACS Group Inc.

      SC 13G - PACS Group, Inc. (0002001184) (Subject)

      11/14/24 5:15:49 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G filed by PACS Group Inc.

      SC 13G - PACS Group, Inc. (0002001184) (Subject)

      11/14/24 5:15:15 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G filed by PACS Group Inc.

      SC 13G - PACS Group, Inc. (0002001184) (Subject)

      11/14/24 11:37:42 AM ET
      $PACS
      Hospital/Nursing Management
      Health Care

    $PACS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • PACS Group Completes Acquisition of Skilled Nursing Facilities in Tennessee

      PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") announced today that independent operating subsidiaries of the Company closed on the operations of 11 skilled nursing facilities in Tennessee on December 1, 2024, which collectively comprise 1,310 skilled nursing beds; a 12th facility in Tennessee is expected to close in the first quarter of 2025, subject to the satisfaction of applicable closing conditions. With the expansion into Tennessee, PACS has now acquired a total of 38 facilities since October 31, 2024, adding 4,700 skilled nursing beds to its portfolio. "We're excited to close these latest acquisitions, which further expand PACS' footprint to 17 states, bringing our services

      12/5/24 4:15:00 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • PACS Group Announces Receipt of Notice of Late Filing from NYSE

      PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), today announced that on November 20, 2024 it received a written Filing Delinquency Notification (the "Notification") from the New York Stock Exchange ("NYSE") stating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual, Annual and Quarterly Report Timely Filing Criteria (the "Timely Filing Criteria"), due to the delayed filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. The Company was unable to timely file its Form 10-Q due to the ongoing Audit Committee investigation of recent third-party allegations. Pursuant to the Notification, the Company has an initial s

      11/26/24 4:30:00 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • U.S. News & World Report Honors 36 PACS Communities

      PACS Group, Inc. (NYSE:PACS) ("PACS") is proud to announce that 36 of its affiliated post-acute communities have been named by U.S. News & World Report to their list of Best Nursing Homes for 2025. Those communities are as follows: Community Name Location All Saints Maubert San Leandro, CA All Saints Subacute & Transitional Care San Leandro, CA Balboa Nursing & Rehabilitation Center San Diego, CA Bel Vista Healthcare Center Long Beach, CA Brushy Creek Post Acute Greer, SC Canyon Vista Post Acute Las Vegas, NV Central Gardens Post Acute San Francisco, CA Citrus Heights Post Acute

      11/19/24 4:00:00 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care

    $PACS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Accounting Officer Lewis Michelle Renee covered exercise/tax liability with 16,777 shares, decreasing direct ownership by 5% to 326,591 units (SEC Form 4)

      4 - PACS Group, Inc. (0002001184) (Issuer)

      4/16/25 7:32:30 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • Chief Compliance Officer Lee Joseph Robert covered exercise/tax liability with 28,763 shares, decreasing direct ownership by 4% to 648,122 units (SEC Form 4)

      4 - PACS Group, Inc. (0002001184) (Issuer)

      4/16/25 7:31:48 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • Officer Sanford Peter covered exercise/tax liability with 72,924 shares, decreasing direct ownership by 5% to 1,280,872 units (SEC Form 4)

      4 - PACS Group, Inc. (0002001184) (Issuer)

      4/16/25 7:31:05 PM ET
      $PACS
      Hospital/Nursing Management
      Health Care

    $PACS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • PACS Group downgraded by Analyst with a new price target

      Analyst downgraded PACS Group from Overweight to Neutral and set a new price target of $18.00

      12/17/24 8:16:05 AM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • JP Morgan resumed coverage on PACS Group with a new price target

      JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00

      11/6/24 6:27:46 AM ET
      $PACS
      Hospital/Nursing Management
      Health Care
    • UBS initiated coverage on PACS Group with a new price target

      UBS initiated coverage of PACS Group with a rating of Buy and set a new price target of $50.00

      10/9/24 7:56:46 AM ET
      $PACS
      Hospital/Nursing Management
      Health Care